Intravenous cyclophosphamide in refractory polyneuropathy associated with IgM monoclonal gammopathy: an uncontrolled open trial

Am J Med. 2005 Apr;118(4):426-30. doi: 10.1016/j.amjmed.2004.12.008.

Authors

Mohamed A Hamidou¹, Cristina Belizna, Sandrine Wiertlewsky, Marie Audrain, Charlotte Biron, Jean-Yves Grolleau, Jean-Marie Mussini

Affiliation

¹ Department of Internal Medicine, University Hospital, Hôtel-Dieu, Place Alexis Ricordeau, Nantes 44-035, France. [email protected]

PMID: 15808143
DOI: 10.1016/j.amjmed.2004.12.008

No abstract available

MeSH terms

Cyclophosphamide / administration & dosage*
Female
Humans
Immunoglobulin M / immunology*
Injections, Intravenous
Male
Middle Aged
Paraproteinemias / complications*
Polyneuropathies / drug therapy*
Prospective Studies
Pulse Therapy, Drug
Treatment Outcome

Substances

Immunoglobulin M
Cyclophosphamide